Vanda Pharmaceuticals
VNDA
VNDA
160 hedge funds and large institutions have $1.2B invested in Vanda Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 57 increasing their positions, 40 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
160
Holders Change
+25
Holders Change %
+18.52%
% of All Funds
3.66%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
39
Increased
57
Reduced
40
Closed
14
Calls
$4.21M
Puts
$1.46M
Net Calls
+$2.74M
Net Calls Change
+$2.78M
Top Buyers
| 1 |
BlackRock
New York
|
$203M |
| 2 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
$40.5M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
$91.1M |
| 4 |
Wells Fargo
San Francisco,
California
|
$15M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
$10.1M |
Top Sellers
| 1 |
ACA
Avoro Capital Advisors
New York
|
$9.87M |
| 2 |
AC
Armistice Capital
New York
|
$20.7M |
| 3 |
Invesco
Atlanta,
Georgia
|
$759K |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
$0 |
| 5 |
Morgan Stanley
New York
|
$11.9M |
